Vanguard Capital Management
ABEO icon

Vanguard Capital Management’s Abeona Therapeutics ABEO Stock Holding History

Vanguard Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7M Buy
2,211,433
+46,582
+2% +$256K ﹤0.01% 2645
2026
Q1 		$9.7M Buy
+2,164,851
New +$10.8M ﹤0.01% 2746

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management's ABEO Position: Q2 2026 in Review

Vanguard Capital Management increased its Abeona Therapeutics (ABEO) stake by 2.2% in Q2 2026, buying an estimated $256K and bringing the position to 2,211,433 shares worth $13.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2645.

Vanguard Capital Management first reported a position in ABEO in Q1 2026 and has held it in 2 quarters since. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Vanguard Capital Management held 2,211,433 shares of Abeona Therapeutics worth $13.7M as of Q2 2026.
  • Vanguard Capital Management bought 46,582 Abeona Therapeutics shares in Q2 2026, an estimated $256K.
  • Abeona Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2645 holding.
  • Vanguard Capital Management first reported a position in Abeona Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.